✦ LIBER ✦

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

✍ Scribed by Eric P Hoffman; Devin Dressman

Book ID: 117340621
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 63 KB
Volume: 22
Category: Article
ISSN: 0165-6147
DOI: 10.1016/s0165-6147(00)01770-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Congenital Muscular Dystrophies: Toward

Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions

✍ James Collins; Carsten G. Bönnemann 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 182 KB

Therapeutics in Duchenne muscular dystro

Therapeutics in Duchenne muscular dystrophy

✍ Strober, Jonathan B. 📂 Article 📅 2006 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 169 KB

Duchenne muscular dystrophy (DMD) is a fatal disorder affecting approximately 1 in 3500 live born males, characterized by progressive muscle weakness. Several different strategies are being investigated in developing a cure for this disorder. Until a cure is found, therapeutic and supportive care is

Therapeutic targeting of signaling pathw

Therapeutic targeting of signaling pathways in muscular dystrophy

✍ Shephali Bhatnagar; Ashok Kumar 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 407 KB

Evolving Therapeutic Strategies for Duch

Evolving Therapeutic Strategies for Duchenne Muscular Dystrophy: Targeting Downstream Events

✍ Tidball, James G; Wehling-Henricks, Michelle 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 744 KB

Vascular-targeted therapies for Duchenne

Vascular-targeted therapies for Duchenne muscular dystrophy

✍ James P Ennen, Mayank Verma, Atsushi Asakura 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 307 KB

Therapeutics for Duchenne muscular dystr

Therapeutics for Duchenne muscular dystrophy: current approaches and future directions

✍ Sasha Bogdanovich; KellyJ. Perkins; ThomasO.B. Krag; TejvirS. Khurana 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 312 KB